WebDec 18, 2007 · SAN DIEGO, Dec. 18 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, announced today that it has made two key additions to its management team. Robert Stefanovich was appointed Chief Financial Officer and Jeffrey Lord was appointed Vice President of Sales. WebJun 19, 2007 · San Diego-based Novalar Pharmaceuticals, Inc. is a privately held specialty pharmaceutical company. The company's initial product offering, NV-101, is being evaluated as a local anesthetic reversal agent and was developed to rapidly reverse the lingering and debilitating lip and tongue numbness associated with local dental anesthesia.
Novalar Pharmaceuticals, Inc. - Dentistry Today
WebReversing the Action of Local Anesthesia. Phentolamine mesylate (0.4 mg in a 1.7 ml cartridge, OraVerse, Novalar Pharmaceuticals, San Diego, CA) is a recently developed agent that shortens the duration of soft-tissue anesthesia. The duration of soft-tissue anesthesia is longer than pulpal anesthesia and is often associated with difficulty ... WebThanks to a ground-breaking product recently introduced by Novalar Pharmaceuticals, Inc., the effects of local dental anesthetics can now be reversed, enabling you to continue on with your day without limitations. That’s because OraVerse, an anesthetic reversal agent, can return you to normal sensation and function in about half the time. chemical idh number
Study of NV-101 for Safety and Efficacy in Pediatric Dental …
WebXeris Pharmaceuticals, Inc. Jan 2024 - Jul 2024 7 months. Greater Chicago Area Shire (Baxalta/Baxter) ... Novalar Pharmaceuticals 2008 - 2009 1 year. Greater Chicago Area Business to Business ... WebMay 30, 2008 · Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, announced May 12 that the United States Food and Drug Administration (FDA) has granted marketing approval for OraVerse™ (phentolamine mesylate). OraVerse is the first pharmaceutical agent indicated for the reversal of soft-tissue anesthesia and the … WebJan 22, 2024 · Chief Medical Officer & Compliance Officer at Novalar Pharmaceuticals Jan 2009 - Jul 2010 . Chief Medical ... MEI Pharma is a San Diego-based clinical-stage pharmaceutical company committed to the development and commercialization of novel, best-in-class, cancer therapies intended to impro ... flight arrivals orlando international